Tension Headache. Chronic tension-type headache
Conditions
Interventions
Intervention 1: Intervention group: Valeriana capsule contain 530 mg Valeriana root powder. Intervention 2: Control group: placebo capsule contain 50 mg breadcrumbs powder.
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Complete written informed consent Age between 18 to 65 years Suffering from common or chronic tension headache based on the International Association Headache (ICHD-III) criteria Be under treatment with medications Not completed treatment (for headache) Informed consent
Exclusion criteria
Exclusion criteria: Patients with uncommon or probable headache or other primary or secondary headaches Headache increases with head movement Metabolic or musculoskeletal disorders that cause similar headache symptoms History of trauma to the spinal cord True or false vertigo Rigidity of the joints, atherosclerosis or advanced arthritis Emotional stress Neurological disorders Taking barbiturates or sedative medications (classic or traditional medicine) The consumption of valerian or its products in the past month Pregnancy and lactation Having underlying disease including diabetes, hypertension, heart disease, liver and kidney disease, and chronic psychological disease History of hypotension (with or without medication) Use of anticoagulants, antiplatelet, heparin, thrombotic agents, opioid analgesics and loperamide Patient headaches improve with taking triptans
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of headache and disability caused by headache are our main outcomes measures. Timepoint: Per 4 weeks. Method of measurement: We will employ HDI and HIT-6 questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHosain Azizi
Iran University of Medical Sciences
Outcome results
None listed